Use of cytokines like IL-2, IL-15, IL-12, IL-21 and IL-18 is considered a promising approach to induction of more efficient NK cell activation at tumor sites, while IL-15 and IL-21 can enhance NK cell cytotoxicity (86). The gene discussed is IL18; the disease is neoplasm.